Safety and Immunogenicity of V116 in Adults With Increased Risk for Pneumococcal Disease (V116-008)
Clinical trial NCT05696080 · COMPLETED
Trial details
- NCT number
- NCT05696080
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-13
- Primary completion
- 2024-02-16
- Enrollment
- 518
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.